Literature DB >> 15975317

Transesophageal echocardiography and stroke.

Timothy D Woods1.   

Abstract

Only coronary artery disease and cancer kill more people than stroke in the United States. Transesophageal echocardiography (TEE) is a semi-invasive ultrasound cardiac imaging technique that provides superior anatomic detail as well as functional information. Searching for a cause of cerebral ischemia is the most common indication for TEE in cardiac ultrasound laboratories. Although TEE is not superior to transthoracic imaging for identifying all sources of cardiac embolism, its ability to more sensitively detect atrial septal aneurysm, patent foramen ovale, and aortic atheroma has been well described in recent years. Care must be exercised in using TEE to identify suspected cardiac sources of embolism, as potential etiologies described in the literature are not equally established by rigorous clinical trials. Confidence level in cause and effect for any cardiac pathology identified must be factored into therapeutic decisions.

Entities:  

Mesh:

Year:  2005        PMID: 15975317     DOI: 10.1007/s11883-005-0016-2

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  46 in total

1.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.

Authors:  J L Mas; C Arquizan; C Lamy; M Zuber; L Cabanes; G Derumeaux; J Coste
Journal:  N Engl J Med       Date:  2001-12-13       Impact factor: 91.245

2.  Lack of evidence of an association between mitral-valve prolapse and stroke in young patients.

Authors:  D Gilon; F S Buonanno; M M Joffe; M Leavitt; J E Marshall; J P Kistler; R A Levine
Journal:  N Engl J Med       Date:  1999-07-01       Impact factor: 91.245

3.  Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus.

Authors:  C Pollick; D Taylor
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

4.  Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants.

Authors:  E Ferrari; R Vidal; T Chevallier; M Baudouy
Journal:  J Am Coll Cardiol       Date:  1999-04       Impact factor: 24.094

5.  Pathologic correlates of aortic plaques, thrombi and mobile "aortic debris" imaged in vivo with transesophageal echocardiography.

Authors:  P Vaduganathan; A Ewton; S F Nagueh; D G Weilbaecher; H J Safi; W A Zoghbi
Journal:  J Am Coll Cardiol       Date:  1997-08       Impact factor: 24.094

6.  Mitral annulus calcification is not an independent risk factor for stroke: a cohort study of 657 patients.

Authors:  A Boon; J Lodder; E Cheriex; F Kessels
Journal:  J Neurol       Date:  1997-09       Impact factor: 4.849

7.  Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.

Authors:  P A Wolf; T R Dawber; H E Thomas; W B Kannel
Journal:  Neurology       Date:  1978-10       Impact factor: 9.910

8.  Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.

Authors:  W J Manning; D I Silverman; C S Keighley; P Oettgen; P S Douglas
Journal:  J Am Coll Cardiol       Date:  1995-05       Impact factor: 24.094

9.  Cardiac involvement in patients with primary antiphospholipid syndrome.

Authors:  B Brenner; Z Blumenfeld; W Markiewicz; S A Reisner
Journal:  J Am Coll Cardiol       Date:  1991-10       Impact factor: 24.094

10.  Protruding atheromas in the thoracic aorta and systemic embolization.

Authors:  P A Tunick; J L Perez; I Kronzon
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

View more
  1 in total

Review 1.  Correlation or causation: untangling the relationship between patent foramen ovale and migraine.

Authors:  Eric Adler; Barry Love; Steve Giovannone; Frank Volpicelli; Martin E Goldman
Journal:  Curr Cardiol Rep       Date:  2007-03       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.